Search engine for other government resources
Irbesartan MedlinePlus Drug InformationIrbesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that ...medlineplus.gov/druginfo/meds/a698009.html Irbesartan C25H28N6O - PubChemIrbesartan is an angiotensin II receptor blocker used alone or in combination with other agents in the therapy of hypertension and diabetic ...pubchem.ncbi.nlm.nih.gov/compound/irbesartan DailyMed - IRBESARTAN tabletIrbesartan USP is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33416f1e-adee-4a45-b6fe-1fc39044e307 Comparison of the antihypertensive efficacy of irbesartan ...This analysis aimed to explore whether low-dose irbesartan/hydrochlorothiazide (HCTZ) has superior blood pressure (BP)-lowering efficacy over low-dose ...pubmed.ncbi.nlm.nih.gov/21091220/ Irbesartan review of pharmacology and comparative ...Irbesartan is well absorbed, does not require biotransformation to an active metabolite to exert its antihypertensive activity, offers a large volume ...pubmed.ncbi.nlm.nih.gov/10822210/ Clinical overview of irbesartan expanding the therapeutic ...Irbesartan: Irbesartan, a new angiotensin II receptor antagonist, has been shown to provide significant blood pressure reductions compared with ...pubmed.ncbi.nlm.nih.gov/9532518/ 
Irbesartan a comprehensive profile - PubMedIrbesartan exerts its action mainly via a selective blockade action on AT1 receptors and the consequent reduced pressor effect of angiotensin II. This ...pubmed.ncbi.nlm.nih.gov/33461698/ Long-term use and tolerability of irbesartan for control ...Irbesartan (Aprovel , Avapro , Irbetan , Karvea ) is a well established angiotensin receptor blocker, approved worldwide for the treatment of ...www.ncbi.nlm.nih.gov/pmc/articles/PMC3172075/ Drug interactions with irbesartan - PubMedIrbesartan is an angiotensin II receptor antagonist indicated for the treatment of patients with hypertension. Although irbesartan does not require ...pubmed.ncbi.nlm.nih.gov/11523726/ Effects of doxazosin and irbesartan on blood pressure and ...Irbesartan had significantly better antihypertensive efficacy than doxazosin (P < 0.05). Doxazosin had the greatest effect on glucose metabolism and ...pubmed.ncbi.nlm.nih.gov/15897788/ Effect of irbesartan on erectile function in patients with ...The angiotensin receptor antagonist irbesartan has been shown to improve endothelial function in cardiovascular high-risk patients, which suggests a ...pubmed.ncbi.nlm.nih.gov/18596705/ Irbesartn MedlinePlus medicinasSu doctor probablemente le dir que no tome irbesartan si usted tiene diabetes y tambin est tomando aliskiren. Informe a su mdico y a su ...medlineplus.gov/spanish/druginfo/meds/a698009-es.html
DailyMed - Search Results for IRBESARTANIRBESARTAN AND HYDROCHLOROTHIAZIDE tablet IRBESARTAN AND HYDROCHLOROTHIAZIDE tablet, film coated. NDC Code(s): 62332-051-10, 62332-051-30, ...dailymed.nlm.nih.gov/dailymed/search.cfm?query=IRBESARTAN Irbesartan Tablets USPIrbesartan USP is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=2a7cc4e3-bf9e-6d21-e054-00144ff8d46c Effects of aerobic exercise training and irbesartan on ...Background and objectives: The present pilot study was undertaken to evaluate the efficacy of an aerobic exercise training (AET) program alone or ...pubmed.ncbi.nlm.nih.gov/18949104/ DailyMed - IRBESARTAN tabletIrbesartan USP is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8635a1c-ae06-4e23-99f7-e704f91d6f43 Pharmaceutical compositions containing irbesartan - Patent ...DESAI DIVYAKANT S (US) Assignee. BRISTOL MYERS SQUIBB CO (US) Date. Priority. 1995/06/07. This web page summarizes information in PubChem about patent ...pubchem.ncbi.nlm.nih.gov/patent/NO-962387-D0 Renal protective effect of SGLT2 inhibitor dapagliflozin ...Combination of dapagliflozin and irbesartan produced more remarkable protective effects on renal function and structure, than use of either agent ...pubmed.ncbi.nlm.nih.gov/29635129/
Modeling of the pharmacokineticpharmacodynamic ...Irbesartan plus hydrochlorothiazide had a greater blood pressure lowering effect compared with irbesartan alone, despite the unchanged irbesartan PK ...pubmed.ncbi.nlm.nih.gov/25545238/ PDF AVAPROIrbesartan is a white to off-white crystalline powder with a molecular weight of 428.5. It is a nonpolar compound with a partition coefficient ...www.accessdata.fda.gov/drugsatfda_docs/label/2014/020757s064lbl.pdf |